SEC Form D · Amendment · filed February 9, 2018
Syros Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (42)
Philip Sharp · Cambridge, MADirectorSrinivas Akkaraju · Cambridge, MADirectorVicki Sato · Cambridge, MADirectorAmir Nashat · Cambridge, MADirectorSanj A. Patel · Cambridge, MADirectorMarsha A. Fanucci · Cambridge, MADirectorRobert Nelsen · Cambridge, MADirectorGerald A. Quirk · Cambridge, MAExecDavid A. Roth · Cambridge, MAExecNancy Simonian · Cambridge, MAExec · DirectorJeremy A. Springhorn · Cambridge, MAExecEric A. Olson · Cambridge, MAExecPeter Wirth · Cambridge, MADirectorRichard A. Young · Cambridge, MADirectorDaniel Perez · San Francisco, CADirectorRichard J. Deslauriers · Woodbury, CTExecBen Blume · San Francisco, CADirectorTeddie Wardi · San Francisco, CADirectorBrad J. Rummer · Dallas, TXDirectorGabriel Mecklenburg · San Francisco, CADirectorDavid E. Smith · Phoenix, AZDirectorAnthony Ardizzone · Phoenix, AZDirectorRobert F. Jacobs · Rowayton, CTExecStephanie Sanborn · Playa Vista, CAExec · DirectorMarc C. Ganzi · Boca Raton, FLDirectorWilliam F. Doyle · New York, NYDirectorJohn Chaffetz · Seattle, WAExecDavid Enslow · Seattle, WAExecJoseph Patt · New York, NYDirectorKevin Prociw · Phoenix, AZDirectorLance Larsen · Port Chester, NYDirectorRyan Larsen · Salt Lake City, UTDirectorRaz Winiarsky · Hackensack, NJDirectorClayton Wood · SEATTLE, WAExecYongbai Choi · SEATTLE, WAExecMark V. Richards · Harlingen, TXDirectorWilliam L. Elliff · Harlingen, TXExecMichael F. Scaief · Harlingen, TXDirectorRobert R. Farris · Harlingen, TXExecTudor G. Uhlhorn · Harlingen, TXDirectorCarlos L. Varela · Harlingen, TXExec · DirectorAndrew Weatherford · Tampa, FLDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗